Literature DB >> 20584250

Photodynamic therapy in dermatology: state-of-the-art.

Philipp Babilas1, Stephan Schreml, Michael Landthaler, Rolf-Markus Szeimies.   

Abstract

Photodynamic therapy (PDT) has become an established treatment modality for dermatooncologic conditions like actinic keratosis, Bowen's disease, in situ squamous cell carcinoma and superficial basal cell carcinoma. There is also great promise of PDT for many non-neoplastic dermatological diseases like localized scleroderma, acne vulgaris, granuloma anulare and leishmaniasis. Aesthetic indications like photo-aged skin or sebaceous gland hyperplasia complete the range of applications. Major advantages of PDT are the low level of invasiveness and the excellent cosmetic results. Here, we review the principal mechanism of action, the current developments in the field of photosensitizers and light sources, practical aspects of topical PDT and therapeutical applications in oncologic as well as non-oncologic indications.

Entities:  

Mesh:

Year:  2010        PMID: 20584250     DOI: 10.1111/j.1600-0781.2010.00507.x

Source DB:  PubMed          Journal:  Photodermatol Photoimmunol Photomed        ISSN: 0905-4383            Impact factor:   3.135


  35 in total

Review 1.  [New developments in laser therapy].

Authors:  P Babilas; M Landthaler
Journal:  Hautarzt       Date:  2012-04       Impact factor: 0.751

2.  Control and utilization of ruthenium and rhodium metal complex excited states for photoactivated cancer therapy.

Authors:  Jessica D Knoll; Claudia Turro
Journal:  Coord Chem Rev       Date:  2015-01-01       Impact factor: 22.315

Review 3.  Management of non-melanoma skin cancer in immunocompromised solid organ transplant recipients.

Authors:  Haider K Bangash; Oscar R Colegio
Journal:  Curr Treat Options Oncol       Date:  2012-09

4.  An Overview Of Photosubstitution Reactions Of Ru(II) Imine Complexes And Their Application In Photobiology And Photodynamic Therapy.

Authors:  Jessica K White; Russell H Schmehl; Claudia Turro
Journal:  Inorganica Chim Acta       Date:  2016-06-18       Impact factor: 2.545

5.  Characterizing low fluence thresholds for in vitro photodynamic therapy.

Authors:  Brad A Hartl; Henry Hirschberg; Laura Marcu; Simon R Cherry
Journal:  Biomed Opt Express       Date:  2015-02-10       Impact factor: 3.732

6.  Toward a 3D cellular model for studying in vitro the outcome of photodynamic treatments: accounting for the effects of tissue complexity.

Authors:  Mireia Alemany-Ribes; María García-Díaz; Marta Busom; Santi Nonell; Carlos E Semino
Journal:  Tissue Eng Part A       Date:  2013-04-19       Impact factor: 3.845

7.  Activating Photodynamic Therapy in vitro with Cerenkov Radiation Generated from Yttrium-90.

Authors:  Brad A Hartl; Henry Hirschberg; Laura Marcu; Simon R Cherry
Journal:  J Environ Pathol Toxicol Oncol       Date:  2016       Impact factor: 3.567

8.  Effect of molecular characteristics on cellular uptake, subcellular localization, and phototoxicity of Zn(II) N-alkylpyridylporphyrins.

Authors:  Rima Ezzeddine; Anwar Al-Banaw; Artak Tovmasyan; James D Craik; Ines Batinic-Haberle; Ludmil T Benov
Journal:  J Biol Chem       Date:  2013-11-08       Impact factor: 5.157

Review 9.  Melanoma resistance to photodynamic therapy: new insights.

Authors:  Ying-Ying Huang; Daniela Vecchio; Pinar Avci; Rui Yin; Maria Garcia-Diaz; Michael R Hamblin
Journal:  Biol Chem       Date:  2013-02       Impact factor: 3.915

10.  Spatiotemporal autophagic degradation of oxidatively damaged organelles after photodynamic stress is amplified by mitochondrial reactive oxygen species.

Authors:  Noemí Rubio; Isabelle Coupienne; Emmanuel Di Valentin; Ingeborg Heirman; Johan Grooten; Jacques Piette; Patrizia Agostinis
Journal:  Autophagy       Date:  2012-08-14       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.